Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03630172 · ClinicalTrials.gov registry record · NA

Dry Needling at the Thoracolumbar Junction on Measures of Sympathetic Outflow and Flexibility

A NA study, sponsored by Nova Southeastern University.

Completed
Registry status
NA
Development phase
54
Enrollment target

NCT03630172 is a NA study that has completed, run by Nova Southeastern University. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03630172, a NA study, has completed, sponsored by Nova Southeastern University.

COMPLETED
Registry status
NA
Development phase
54 participants
Enrollment target

Study Summary

Dry needling (DN) is becoming more frequently performed by physical therapists around the world to treat musculoskeletal pain. Dry needling is a form of trigger point therapy that evolved from using injections of local anesthetics. Although dry needling is becoming more commonly used, there is little agreement on how it works. Researchers have focused their efforts investigating other forms of manual therapy until very recently. To date, no studies have looked at how dry needling effects muscles distant from the area being treated. Most of the body's sympathetic nervous system (fight or flight response) is located in the thoracic spine, it may be a "silent" contributor to musculoskeletal problems in the arms and legs. The purpose of this study is to determine how dry needling the thoracolumbar junction affects pain, flexibility, and other non-invasive measures of nervous system output in people who have low back pain and tightness of their hamstring muscles. Standard dry needling treatment will be compared with a placebo. The investigators hypothesize that dry needling will have a greater sympathetic nervous system response, as measured by changes in heart rate, skin temperature and skin conductance, when compared with the placebo. The investigators also hypothesize that dry needling will have a greater positive effect on flexibility of the low back and hamstring muscles when compared to the placebo.

Interventions

  • PROCEDURE Dry needling

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2018-09-15
Est. Completion 2019-08-10
Phase NA

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT03630172

The ClinicalTrials.gov registry entry for NCT03630172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dry needling is the first listed.

NCT03630172 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03630172 about?

NCT03630172 is a clinical study titled "Dry Needling at the Thoracolumbar Junction on Measures of Sympathetic Outflow and Flexibility". Dry needling (DN) is becoming more frequently performed by physical therapists around the world to treat musculoskeletal pain. Dry needling is a form of trigger point therapy that evolved from using injections of local anesthetics. Although dry needling is becoming more commonly used, there is littl...

What is the current status of trial NCT03630172?

This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2018-09-15. Estimated completion is 2019-08-10.

What interventions are being tested in trial NCT03630172?

The interventions under investigation include: Dry needling (PROCEDURE).

Who is sponsoring clinical trial NCT03630172?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.